Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH

Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.
Latest website image capture
Clouds background image

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, reflecting a new build of the page. This is a metadata/version update rather than a change to study content or results.
    Difference
    0.0%
    Check dated 2026-05-17T10:45:57.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page’s interface revision/build indicator in the footer has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release version change rather than a change to the study information.
    Difference
    0.0%
    Check dated 2026-04-25T18:35:08.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:28:29.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a platform revision entry v3.5.0 and removed the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-28T01:29:21.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the site.
    Difference
    0.0%
    Check dated 2026-03-06T18:01:58.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:22:32.000Z thumbnail image

Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH

Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.